Studies have shown that the expression level of GPC3 is elevated in HCC patients 19, and the heparin sulfate chain of GPC3 interacts with heparin-binding growth factors and other growth factors, such as HGF and VEGF, to promote the development of HCC 20. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.